FREVOYCE
"FREVOYCE" is a word mark owned by Takeda Pharmaceuticals International AG, filed at the USPTO on March 6, 2025. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since August 26, 2025
- Filed
- March 6, 2025
- Registered
- August 26, 2025
- Priority date
- March 5, 2025
- Claimed from Switzerland
- Application no.
- 99070945
- Registration no.
- 7921853
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns FREVOYCE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Takeda Pharmaceuticals International AG
Glattpark-Opfikon, Switzerland
Representative
Karl M. Zielaznicki
Troutman Pepper Locke LLP
What the mark covers
The products and services FREVOYCE is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of autoimmune disorders
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Assigned to lie
- Teas response to suspension inquiry received
9 earlier steps on the official record.
About FREVOYCE
Who owns the trademark "FREVOYCE"?
The USPTO trademark "FREVOYCE" (application 99070945) is owned by Takeda Pharmaceuticals International AG.
What is the status of "FREVOYCE"?
Its status at the USPTO is: registered.
When was "FREVOYCE" registered?
It was registered on August 26, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull FREVOYCE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a85-85ca-7278-af25-8ae885bfef0e
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a85-85ca-7278-af25-8ae885bfef0e",
"object": "trademark",
"mark_text": "FREVOYCE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "99070945",
"filing_date": "2025-03-06",
"nice_classes": [
5
],
"owners": [
{
"name": "Takeda Pharmaceuticals International AG",
"entity_id": "ent_019f285e-b1bf-774b-b715-7a687387e84f"
}
]
}